Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Peyrottes

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
World Journal of Urology|June 20, 2025
Persistence of nocturia after BPH surgery: a multicenter studyThibaut Long Depaquit, Christopher Aguëro, Alessandro Uleri, et al.
World Journal of Urology|June 7, 2025
Tailoring prostate cancer external beam radiotherapy for patients with lower urinary tract symptomsJennifer Le Guévelou, Romain Mathieu, Arthur Peyrottes, et al.
European Urology Oncology|June 1, 2024
Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic ReviewMichael Baboudjian, Arthur Peyrottes, Charles Dariane, et al.
The French Journal of Urology|April 1, 2026
A single-centre Assessment of Short-Term Functional Outcomes of Holmium Laser Enucleation vs. Robot-Assisted Simple Prostatectomy for Medium and Large-Volume Benign Prostatic HyperplasiaAlexandre Gac, Maxime Pattou, Jérémie Gallon, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Prostate cancer - Management of metastatic disease and castration resistanceGuillaume Ploussard, Charles Dariane, Romain Mathieu, et al.
Urologic Oncology|May 29, 2026
ISUP 2 prostate cancer with suspicion of extraprostatic extension on MRI: Prostatectomy results and oncologic outcomesNorbert De Brek, Arthur Peyrottes, Romain Diamand, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Prostate cancer - Diagnosis and management of localised diseaseGuillaume Ploussard, Michaël Baboudjian, Eric Barret, et al.
European Urology Oncology|February 18, 2025
Active Surveillance of Grade Group 2 Prostate Cancer: Oncological Outcomes from a Contemporary European CohortMichael Baboudjian, Riccardo Leni, Marco Oderda, et al.
Prostate Cancer and Prostatic Diseases|April 29, 2025
Gleason pattern 4 and active surveillance in patients with grade group 2 prostate cancerAlessandro Uleri, Michael Baboudjian, Riccardo Leni, et al.
The French Journal of Urology|October 18, 2025
French recommendations from the AFU Cancer Committee for prostate cancer: 2025 summary of changesGuillaume Ploussard, Michaël Baboudjian, Eric Barret, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
World Journal of Urology|June 20, 2025
Persistence of nocturia after BPH surgery: a multicenter studyThibaut Long Depaquit, Christopher Aguëro, Alessandro Uleri, et al.
World Journal of Urology|June 7, 2025
Tailoring prostate cancer external beam radiotherapy for patients with lower urinary tract symptomsJennifer Le Guévelou, Romain Mathieu, Arthur Peyrottes, et al.
European Urology Oncology|June 1, 2024
Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic ReviewMichael Baboudjian, Arthur Peyrottes, Charles Dariane, et al.
The French Journal of Urology|April 1, 2026
A single-centre Assessment of Short-Term Functional Outcomes of Holmium Laser Enucleation vs. Robot-Assisted Simple Prostatectomy for Medium and Large-Volume Benign Prostatic HyperplasiaAlexandre Gac, Maxime Pattou, Jérémie Gallon, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Prostate cancer - Management of metastatic disease and castration resistanceGuillaume Ploussard, Charles Dariane, Romain Mathieu, et al.
Urologic Oncology|May 29, 2026
ISUP 2 prostate cancer with suspicion of extraprostatic extension on MRI: Prostatectomy results and oncologic outcomesNorbert De Brek, Arthur Peyrottes, Romain Diamand, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Prostate cancer - Diagnosis and management of localised diseaseGuillaume Ploussard, Michaël Baboudjian, Eric Barret, et al.
European Urology Oncology|February 18, 2025
Active Surveillance of Grade Group 2 Prostate Cancer: Oncological Outcomes from a Contemporary European CohortMichael Baboudjian, Riccardo Leni, Marco Oderda, et al.
Prostate Cancer and Prostatic Diseases|April 29, 2025
Gleason pattern 4 and active surveillance in patients with grade group 2 prostate cancerAlessandro Uleri, Michael Baboudjian, Riccardo Leni, et al.
The French Journal of Urology|October 18, 2025
French recommendations from the AFU Cancer Committee for prostate cancer: 2025 summary of changesGuillaume Ploussard, Michaël Baboudjian, Eric Barret, et al.
Pageof 6